An user acceptability study of vaginal spermicides in combination with barrier methods or an IUCD.
Ninety-eight women were entered into an open study of Staycept jelly (octoxynol 1% w/w) and Staycept pessaries (vaginal suppositories) (nonoxynol-9 6% w/w) in combination with other vaginal methods of contraception. Medical problems during use of either pessary or jelly were few and were restricted to genital irritation or increased vaginal discharge. This seemed more common with the pessaries than with the jelly, but this could have been related to the types of women entered. There were no unplanned pregnancies.
D003274:Contraceptive Devices, Female; D005260:Female; D006801:Humans; D007435:Intrauterine Devices, Copper; D017830:Octoxynol; D010342:Patient Acceptance of Health Care; D010349:Patient Compliance; D010570:Pessaries; D011092:Polyethylene Glycols; D013089:Spermatocidal Agents; D014622:Vaginal Creams, Foams, and Jellies
D013089:Spermatocidal Agents; D014622:Vaginal Creams, Foams, and Jellies; D011092:Polyethylene Glycols; D017830:Octoxynol